| Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells M Akdis, J Verhagen, A Taylor, F Karamloo, C Karagiannidis, R Crameri, ... The Journal of experimental medicine 199 (11), 1567-1575, 2004 | 1489 | 2004 |
| Mechanisms of immune suppression by interleukin‐10 and transforming growth factor‐β: the role of T regulatory cells A Taylor, J Verhagen, K Blaser, M Akdis, CA Akdis Immunology 117 (4), 433-442, 2006 | 902 | 2006 |
| Regulation of adaptive immunity; the role of interleukin-10 THS Ng, GJ Britton, EV Hill, J Verhagen, BR Burton, DC Wraith Frontiers in immunology 4, 129, 2013 | 443 | 2013 |
| Absence of T-regulatory cell expression and function in atopic dermatitis skin J Verhagen, M Akdis, C Traidl-Hoffmann, P Schmid-Grendelmeier, ... Journal of allergy and clinical immunology 117 (1), 176-183, 2006 | 372 | 2006 |
| Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cells L Gabryšová, KS Nicolson, HB Streeter, J Verhagen, CA Sabatos-Peyton, ... Journal of Experimental Medicine 206 (8), 1755-1767, 2009 | 197 | 2009 |
| Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy BR Burton, GJ Britton, H Fang, J Verhagen, B Smithers, ... Nature communications 5 (1), 4741, 2014 | 192 | 2014 |
| Antigen-specific immunotherapy of autoimmune and allergic diseases CA Sabatos-Peyton, J Verhagen, DC Wraith Current opinion in immunology 22 (5), 609-615, 2010 | 176 | 2010 |
| A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-γ-inducible protein 10, monokine induced by IFN-γ, and IFN-γ … S Klunker, A Trautmann, M Akdis, J Verhagen, P Schmid-Grendelmeier, ... The Journal of Immunology 171 (2), 1078-1084, 2003 | 139 | 2003 |
| Comment on “Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory … J Verhagen, DC Wraith The Journal of Immunology 185 (12), 7129-7129, 2010 | 134 | 2010 |
| T regulatory cells in allergy and health: a question of allergen specificity and balance A Taylor, J Verhagen, CA Akdis, M Akdis International archives of allergy and immunology 135 (1), 73-82, 2004 | 116 | 2004 |
| IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation RE Mitchell, M Hassan, BR Burton, G Britton, EV Hill, J Verhagen, ... Scientific reports 7 (1), 11315, 2017 | 111 | 2017 |
| Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more J Verhagen, K Blaser, CA Akdis, M Akdis Immunology and Allergy Clinics 26 (2), 207-231, 2006 | 76 | 2006 |
| Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease J Verhagen, L Gabryšová, S Minaee, CA Sabatos, G Anderson, ... Proceedings of the National Academy of Sciences 106 (9), 3306-3311, 2009 | 66 | 2009 |
| CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire J Verhagen, R Genolet, GJ Britton, BJ Stevenson, CA Sabatos-Peyton, ... Proceedings of the National Academy of Sciences 110 (3), E221-E230, 2013 | 64 | 2013 |
| T regulatory cells and allergy A Taylor, J Verhagen, CA Akdis, M Akdis Microbes and infection 7 (7-8), 1049-1055, 2005 | 52 | 2005 |
| Myeloid‐derived suppressor cells mediate tolerance induction in autoimmune disease A Wegner, J Verhagen, DC Wraith Immunology 151 (1), 26-42, 2017 | 49 | 2017 |
| Human CD4+ T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential J Verhagen, ED van Der Meijden, V Lang, AE Kremer, S Völkl, ... Clinical & Experimental Immunology 205 (3), 363-378, 2021 | 35 | 2021 |
| IL-10 suppresses CD2-mediated T cell activation via SHP-1 A Taylor, J Verhagen, T Akkoç, R Wenig, E Flory, K Blaser, M Akdis, ... Molecular immunology 46 (4), 622-629, 2009 | 32 | 2009 |
| Extra‐thymically induced T regulatory cell subsets: the optimal target for antigen‐specific immunotherapy J Verhagen, A Wegner, DC Wraith Immunology 145 (2), 171-181, 2015 | 28 | 2015 |
| The role of CTLA-4 in immune regulation J Verhagen, CA Sabatos, DC Wraith Immunology letters 115 (1-4), 73, 2008 | 28 | 2008 |
